NeuroMetrix Announces Deal with Rehabiliation Mgmt Group, OsteoArthritis Centers of America for SENSUS System

Loading...
Loading...
NeuroMetrix, Inc.
NURO
, a medical device company focused on the treatment and management of chronic pain, today announced that it had entered into an agreement with OsteoArthritis Centers of America, a subsidiary of Rehabilitation Management Group (RMG) which is a national physician consulting company, to incorporate the SENSUS^™ Pain Management System into its affiliated medical clinics. The SENSUS Pain Management System is a convenient and wearable non-invasive electrical nerve stimulator that offers patients a fast-acting, non-narcotic option for relief from chronic pain. The device is lightweight and can be worn during the day while remaining active, or at night while sleeping. It is specifically designed for people with diabetes that suffer from chronic pain. The most common cause of such pain is painful diabetic neuropathy (PDN), which affects up to 5 million people in the U.S. alone. There are over 100 medical clinics throughout the US that operate as affiliates of RMG and the Osteoarthritis Centers of America. Accredited providers offer a variety of services to their patients including programs to relieve chronic pain, such as that due to painful diabetic neuropathy. A growing number of clinics offer RMG's proprietary Neuropathy Medical Program. As part of this agreement, SENSUS will be incorporated into the program as an option when medically indicated.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsContracts
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...